Ovid therapeutics Contact Number

All Time Past 24 Hours Past Week Past month Post Your Comments?

Listing Results Ovid therapeutics Contact Number

Contact Ovid Therapeutics

7 hours ago Ovidrx.com Get All

See our headquarters, other locations, and get contact information for media inquiries, investor relations, partnering inquires, or general contact needs.

Website: https://ovidrx.com/contact/

Category: Contact SupportShow more

Ovid Therapeutics Crunchbase Company Profile & Funding

7 hours ago Crunchbase.com Get All

(212) 776-4381Legal Name Ovid Therapeutics Inc. Stock Symbol NASDAQ:OVID. Company Type For Profit. Contact Email [email protected] Phone Number (212) 776-4381. Ovid is a …

Founded: 2014
Founder: Matthew During

Website: https://www.crunchbase.com/organization/ovid-therapeutics

Category: Contact NumberShow more

Ovid Therapeutics Impactful Medicines for Rare

9 hours ago Ovidrx.com Get All

the. lives of individuals with rare. neurological diseases. Science-driven and patient-focused, our mission is to bring treatments to individuals with rare neurological …

Website: https://ovidrx.com/

Category: Contact NumberShow more

An OpenLabel Study to Evaluate the LongTerm Safety

1 hours ago Clinicaltrials.gov Get All

855-235-3138Contact: Ovid - ELARA angelmanstudy.com 855-235-3138 [email protected] : United States, Massachusetts: Ovid Therapeutics Investigative Site: …

Estimated Enrollment : 82 participants
Study Type : Interventional (Clinical Trial)
Intervention Model: Single Group Assignment

Website: https://www.clinicaltrials.gov/ct2/show/NCT03882918

Category: Contact NumberShow more

Ovid Therapeutics Company Profile Office Locations

4 hours ago Craft.co Get All

Ovid Therapeutics has 51 employees across 2 locations and $12.62 M in annual revenue in FY 2020. See insights on Ovid Therapeutics including office locations …

Founded: 2014
Website: ovidrx.com
Type: Public

Website: https://craft.co/ovid-therapeutics

Category: Contact NumberShow more

Ovid Therapeutics Email Format ovidrx.com Emails

Just Now Rocketreach.co Get All

Ovid Therapeutics Email Format. Ovid Therapeutics uses 2 email formats, with first_initial last (ex. [email protected]) being used 87.9% of the time. Get …

Website: https://rocketreach.co/ovid-therapeutics-email-format_b55f9136f6b4a162

Category: Contact NumberShow more

FAQs Ovid Therapeutics Inc.

3 hours ago Investors.ovidrx.com Get All

Ovid Therapeutics, Inc. Suite 15044 1460 Broadway New York, NY 10036

Website: https://investors.ovidrx.com/investor-resources/faqs/

Category: Contact NumberShow more

Contact information – Get in touch with ProQR Therapeutics

9 hours ago Proqr.com Get All

Office Cambridge. 245 Main Street (2nd Floor) Cambridge, MA 02142 USA

Website: https://www.proqr.com/contact

Category: Contact SupportShow more

Ovid Therapeutics Inc. (OVID) Company Profile & Facts

5 hours ago Finance.yahoo.com Get All

See the company profile for Ovid Therapeutics Inc. (OVID) including business summary, industry/sector information, number of employees, business summary, corporate …

Website: https://finance.yahoo.com/quote/OVID/profile/

Category: Contact NumberShow more

Ovid: Welcome to Ovid

4 hours ago Ovidsp.ovid.com Get All

Buy immediate access to full text content from the latest, most trusted journals

Website: https://ovidsp.ovid.com/

Category: Contact NumberShow more

A Study of OV101 in Individuals With ClinicalTrials.gov

7 hours ago Clinicaltrials.gov Get All

You have reached the maximum number of saved studies (100). you or your doctor may contact the study research staff using the contacts provided below. For …

Website: https://clinicaltrials.gov/ct2/show/NCT04106557

Category: Contact NumberShow more

Ovid Therapeutics (OVID) Company Profile & Overview

6 hours ago Stockanalysis.com Get All

Company profile for Ovid Therapeutics, including a description, list of executives, contact details and other key facts. Company profile for Ovid Therapeutics

Website: https://stockanalysis.com/stocks/ovid/company/

Category: Contact NumberShow more

Locating Sites For COVID19 Antibody Treatments

5 hours ago Infusioncenter.org Get All

855-545-5921Contact your local/regional health authorities ; or • Call the Li lly COVID Hotline at . 1-855-LillyC19 (1-855-545-5921) to inquire about sites that have received …

Website: http://infusioncenter.org/wp-content/uploads/2021/01/Locating-Sites-Providing-COVID-19-Antibody-Treatments_0112.pdf

Category: Contact NumberShow more

OVID Graham Number Ovid Therapeutics GuruFocus.com

6 hours ago Gurufocus.com Get All

Ovid Therapeutics's graham number for the quarter that ended in Jun. 2021 was $10.73. Therefore, Ovid Therapeutics's Price to Graham Number ratio for today …

Website: https://www.gurufocus.com/term/grahamnumber/NAS:OVID/Graham%252BNumber/Ovid%2BTherapeutics%2BInc

Category: Contact NumberShow more

Contact Us J&J's Janssen COVID19 Vaccine

8 hours ago Janssencovid19vaccine.com Get All

800-565-4008If you have product-related questions, please contact a specialist: US Toll Free: 1-800-565-4008 1-800-565-4008 US Toll: 1-908-455-9922 1-908-455-9922

Website: https://www.janssencovid19vaccine.com/for-recipients/contact-us.html

Category: Contact SupportShow more

Ovid Therapeutics Inc. (OVID) Latest News and Helpful

1 hours ago Baxterreport.com Get All

The total number of common shares currently owned by the public is 66.09 million. OVID does have institutional investors; and they hold 53.70% of the stock. Ovid

Website: https://baxterreport.com/2021/07/06/ovid-therapeutics-inc-ovid-latest-news-and-helpful-information-3/

Category: Contact NumberShow more

LWW HEALTH LIBRARY Wolters Kluwer

9 hours ago Wolterskluwer.com Get All

710 278 35Number of titles 710 278 35 37 41 40 13 25 26 18 1523 16 21 24 2822 29 Therapeutics Jones, Patient Assessment in Pharmacy Practice Shargel, Comprehensive …

Website: https://www.wolterskluwer.com/-/media/project/wolterskluwer/oneweb/www/health/hlrp/solutions/ovid/documents/factsheet-lww-health-library-tri-fold.pdf

Category: Contact NumberShow more

OVID Stock Ovid Therapeutics Inc. SEC Filings

Just Now Sec.report Get All

Ovid Therapeutics Inc is primarely in the business of pharmaceutical preparations. For financial reporting, their fiscal year ends on December 31st. This page includes …

Website: https://sec.report/Ticker/OVID

Category: Contact NumberShow more

Ovid Therapeutics Initiates Pivotal Phase 3 Clinical Trial

2 hours ago Investors.ovidrx.com Get All

NEW YORK, June 27, 2019 (GLOBE NEWSWIRE) -- Ovid Therapeutics Inc. (NASDAQ: OVID), today announced that following a Type C Meeting with the U.S. Food and Drug …

Website: https://investors.ovidrx.com/news-releases/news-release-details/ovid-therapeutics-initiates-pivotal-phase-3-clinical-trial

Category: Contact NumberShow more

OVID THERAPEUTC Number of Employees 20162021 OVID

2 hours ago Macrotrends.net Get All

OVID THERAPEUTC number of employees from 2016 to 2021. Number of employees can be defined as a measure of financial performance calculated as operating cash flow …

Website: https://www.macrotrends.net/stocks/charts/OVID/ovid-therapeutc/number-of-employees

Category: Contact NumberShow more

OVID Ovid Therapeutics Inc. Profile MarketWatch

4 hours ago Marketwatch.com Get All

Ovid Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of medicines for patients and families living with rare neurological …

Website: https://www.marketwatch.com/investing/stock/ovid/company-profile

Category: Contact NumberShow more

Ovid Therapeutics Reports Second Quarter 2021 Financial

6 hours ago Finance.yahoo.com Get All

917-943-6681Contacts. Investors and Media: Meg Alexander Ovid Therapeutics Inc. Investor Relations & Public Relations 917-943-6681 [email protected] OR. Investors:

1. Author: Ovid Therapeutics Inc.

Website: https://finance.yahoo.com/news/ovid-therapeutics-reports-second-quarter-120000953.html

Category: Contact NumberShow more

Jeremy Levin Biotechnology Innovation Organization (BIO

8 hours ago Informaconnect.com Get All

Jeremy M. Levin, D.Phil, MBBChirDr. Jeremy Levin is the Chairman and CEO of Ovid Therapeutics, Inc. (NASDAQ: OVID) a publiccompany developing novel medicines for …

Website: https://informaconnect.com/biotech-showcase/speakers/jeremy-levin-1/

Category: Tech SupportShow more

OVID Stock Price Ovid Therapeutics Inc. Stock Quote (U.S

8 hours ago Marketwatch.com Get All

Ovid Therapeutics (OVID) Gets a Buy Rating from Ladenburg Thalmann & Co. Mar. 4, 2021 at 6:45 a.m. ET on SmarterAnalyst OVID Stock News: The Big Deal That Has …

Website: https://www.marketwatch.com/investing/stock/ovid

Category: Contact NumberShow more

What Do Analysts Think Of Ovid Therapeutics Inc. (OVID

9 hours ago Baxterreport.com Get All

The total number of common shares currently owned by the public is 67.82 million. OVID does have institutional investors; and they hold 49.60% of the stock. Ovid

Website: https://baxterreport.com/2021/08/27/what-do-analysts-think-of-ovid-therapeutics-inc-ovid/

Category: Contact NumberShow more

Ovid Therapeutics Stock price prediction 2021 (NASDAQ:OVID)

6 hours ago Macroaxis.com Get All

The number of cover stories for Ovid Therapeutics depends on current market conditions and Ovid Therapeutics' risk-adjusted performance over time. The coverage …

Website: https://www.macroaxis.com/predict/OVID/Ovid-Therapeutics

Category: Contact NumberShow more

Ovid Therapeutics Inc. DEF 14A Apr. 23, 2020 5:37 PM

9 hours ago Seekingalpha.com Get All

Ovid Therapeutics Inc. If your shares are held in street name, please contact the telephone number provided on your voting instruction form or contact your …

Website: https://seekingalpha.com/filing/4942041

Category: Contact NumberShow more

OVID Is Its Stock Price A Worthy Investment? Learn More.

3 hours ago Stocknews.com Get All

Revenue growth over the past 12 months for Ovid Therapeutics Inc comes in at 1,651.57%, a number that bests 99.3% of the US stocks we're tracking. Stocks that are …

Website: https://stocknews.com/stock/OVID/

Category: Contact NumberShow more

Ovid Therapeutics Funding, Financials, Valuation & Investors

6 hours ago Crunchbase.com Get All

Ovid Therapeutics has raised a total of $134.1M in funding over 4 rounds. Their latest funding was raised on Feb 26, 2019 from a Post-IPO Equity round. Ovid

Website: https://www.crunchbase.com/organization/ovid-therapeutics/company_financials

Category: Contact NumberShow more

oviddef14a_20210610.htm SEC

1 hours ago Sec.gov Get All

1460 Broadway, Suite 15044. New York, NY 10036. April 29, 2021 . Dear Stockholder: You are cordially invited to attend the 2021 Annual Meeting of Stockholders (“Annual …

Website: https://www.sec.gov/Archives/edgar/data/1636651/000156459021022189/ovid-def14a_20210610.htm

Category: Contact NumberShow more

Takeda Secures Global Rights from Ovid Therapeutics to

3 hours ago Takeda.com Get All

(866) 830-1640The live event will be available on the investor page of the Ovid Therapeutics website at investors.ovidrx.com or by dialing (866) 830-1640 (domestic) or (210) …

Website: https://www.takeda.com/newsroom/newsreleases/2021/takeda-secures-global-rights-from-ovid-therapeutics-to-develop-and-commercialize-soticlestat-for-the-treatment-of-children-and-adults-with-dravet-syndrome-and-lennox-gastaut-syndrome/

Category: Contact NumberShow more

OVID Ovid Therapeutics Stock Price Barchart.com

3 hours ago Barchart.com Get All

OVID : 3.50 (-0.28%) 2 Top Biotech Stocks to Buy Under $10 stocknews.com - Thu Jul 15, 9:39AM CDT. The COVID-19 pandemic brought renewed interest in the biotech …

Website: https://www.barchart.com/stocks/quotes/OVID

Category: Contact NumberShow more

OVID: Average Analyst Price Target is $4.88

6 hours ago Stocknews.com Get All

The number of analysts covering the stock of OVID is higher than 34.42% of Pharmaceutical Products stocks. In terms of price targets and recommendations offered by …

Website: https://stocknews.com/stock/OVID/price-target/

Category: Contact NumberShow more

Ovid Therapeutics Stock Analysis 2021 OVID Macroaxis

3 hours ago Macroaxis.com Get All

The company was incorporated in 2014 and is headquartered in New York, New York. Ovid Therapeutics operates under Biotechnology classification in the United States …

Website: https://www.macroaxis.com/stock-analysis/OVID/Ovid-Therapeutics

Category: Contact NumberShow more

Thinking Of Selling Ovid Therapeutics Inc. (NASDAQ: OVID

9 hours ago Stocksregister.com Get All

According to the data, the short interest in Ovid Therapeutics Inc. (OVID) stood at 6.83% of shares outstanding as of Apr 14, 2021; the number of short shares …

Website: https://stocksregister.com/2021/08/14/thinking-of-selling-ovid-therapeutics-inc-nasdaq-ovid-stock-check-this-out-first/

Category: Contact NumberShow more

After Falling 6.09% During The Past Week, Should You

6 hours ago Marketingsentinel.com Get All

Ovid Therapeutics Inc. (NASDAQ:OVID)’s traded shares stood at 0.47 million during the last session, with the company’s beta value hitting 1.80. At the close of …

Website: https://marketingsentinel.com/2021/07/17/after-falling-6-09-during-the-past-week-should-you-still-buy-ovid-therapeutics-inc-nasdaq-ovid/

Category: Contact NumberShow more

OVID Insider Trading Ovid Therapeutics Inc. Form 4 SEC

2 hours ago Secform4.com Get All

Ovid Therapeutics Inc. sec form 4 filings insider trading, stock buying and selling.

Website: https://www.secform4.com/insider-trading/1636651.htm

Category: Contact NumberShow more

OVID THERAPEUTICS INC. : OVID Stock Price US6904691010

4 hours ago Marketscreener.com Get All

Ovid Therapeutics Inc. is a biopharmaceutical company focused on developing medicines for patients and families living with rare neurological disorders. The …

Website: https://www.marketscreener.com/quote/stock/OVID-THERAPEUTICS-INC-34771447/

Category: Contact NumberShow more

Takeda and Ovid Therapeutics Announce Innovative Clinical

2 hours ago Takeda.com Get All

12.29.235

1. Under the terms of the agreement, Takeda received equity in Ovid and may be eligible to receive certain milestone payments based on the advancement of TAK-935. The companies will share in the development and commercialization costs on a 50/50 basis and, if successful, the companies will share in the profits on a 50/50 basis. Takeda will lead commercialization in Japan, and has the option to lead in Asia and other selected geographies. Ovid will lead clinical development activities and commercialization of TAK-935 in the United States, Europe, Canada and Israel. All activities of the collaboration regarding TAK-935 will be guided by the Takeda/Ovid “One Team” concept, an integrated and interdisciplinary team from both companies devoted to the successful advancement of TAK-935 across rare epilepsy syndromes. If mutually agreed, additional orphan central nervous system indications may also be pursued. Additional financial details were not disclosed. “Ovid’s agility, exclusive focus on...

Website: https://www.takeda.com/newsroom/newsreleases/2017/Takeda-and-Ovid-Therapeutics-Announce-Innovative-Clinical-Development-and-Commercialization/

Category: Contact NumberShow more

Ovid Therapeutics Misses Earnings Whispers

8 hours ago Earningswhispers.com Get All

Ovid Therapeutics Misses . Ovid Therapeutics (OVID) reported a 2nd Quarter June 2021 loss of $0.23 per share on revenue of $0.0 million. The consensus estimate was …

Website: https://www.earningswhispers.com/epsdetails/ovid

Category: Contact NumberShow more

Initial Statement of Beneficial Ownership (3)

7 hours ago Ih.advfn.com Get All

Initial Statement of Beneficial Ownership (3) 1. Name and Address of Reporting Person * Poole Robert Michael. 2. Date of Event Requiring Statement (MM/DD/YYYY) 7/9/2021.

Website: https://ih.advfn.com/stock-market/NASDAQ/ovid-therapeutics-OVID/stock-news/85568616/initial-statement-of-beneficial-ownership-3

Category: Contact NumberShow more

Ovid Therapeutics Earnings Date, Forecast and Report

5 hours ago Marketbeat.com Get All

Ovid Therapeutics has generated ($1.39) earnings per share over the last year ($1.68 diluted earnings per share) and currently has a price-to-earnings ratio of 2.1.

Website: https://www.marketbeat.com/stocks/NASDAQ/OVID/earnings/

Category: Contact NumberShow more

OVID Ovid Therapeutics Stock Interactive Chart

1 hours ago Barchart.com Get All

The number of points the security must move before a new brick is formed. Column : Much like Line and Area charts, a Column chart plots a vertical bar for the close.

Website: https://www.barchart.com/stocks/quotes/OVID/interactive-chart

Category: Contact NumberShow more

Ovid Therapeutics : Reports Fourth Quarter and Full Year

5 hours ago Marketscreener.com Get All

NEW YORK, March 15, 2021 (GLOBE NEWSWIRE) -- Ovid Therapeutics Inc. (NASDAQ: OVID) (“Ovid”), a biopharmaceutical company committed to developing medicines that …

Website: https://www.marketscreener.com/quote/stock/OVID-THERAPEUTICS-INC-34771447/news/Ovid-Therapeutics-Reports-Fourth-Quarter-and-Full-Year-2020-Financial-Results-Provides-Corporate-32686490/

Category: Contact NumberShow more

Amended Current Report Filing (8k/a)

9 hours ago Ih.advfn.com Get All

254903117 v1. Explanatory Note. In accordance with Instruction No. 2 to Item 5.02 of Form 8-K, this Current Report on Form 8-K/A (the “Amendment Filing”) updates the …

Website: https://ih.advfn.com/stock-market/NASDAQ/ovid-therapeutics-OVID/stock-news/85813311/amended-current-report-filing-8-k-a

Category: Contact NumberShow more

SRO List Food and Drug Administration

3 hours ago Accessdata.fda.gov Get All

3. SRO List. -. You can search the list by entering the DUNS NUMBER, BUSINESS NAME, or TICKER SYMBOL in the search criteria. The SRO list is a comprehensive and …

Website: https://www.accessdata.fda.gov/scripts/SDA/sdNavigation.cfm?sd=srolist&displayAll=false&page=10

Category: Contact NumberShow more

All Time Past 24 Hours Past Week Past month

Please leave your comments here:

Brand New Updated

Frequently Asked Questions

Who is the founder of Ovid Therapeutics Inc?

Ovid Therapeutics Inc. Ovid Therapeutics, Inc. focuses on developing medicines for patients and families living with rare neurological disorders. The company was founded by Matthew During in April 2014 and is headquartered in New York, NY.

Is there a watchlist for Ovid Therapeutics?

There are currently no items in this Watchlist. Create a list of the investments you want to track. Something went wrong while loading Watchlist. Visit a quote page and your recently viewed tickers will be displayed here. Ovid Therapeutics, Inc. focuses on developing medicines for patients and families living with rare neurological disorders.

What is the average analyst price target for Ovid?

Ovid Therapeutics Inc's average analyst price target is greater than 11.03% of all US stocks. The variance in analysts' estimates of OVID is lower than 14.01% of all US stocks. OVID has a greater upside potential (average analyst target price relative to current price) than 24.75% of Pharmaceutical Products stocks.

Why are rare diseases important to Ovid Therapeutics?

Our deep understanding of human genetics and cellular function enables us to translate discoveries into meaningful therapies for rare neurological diseases. At Ovid, we seek to understand what matters most to individuals with rare diseases and their families.

Popular Brands

Olam
Oracle
Orix
Okta
Oneok
Omv
Orpea
Orsted
Opera
Omron